Invention Grant
- Patent Title: IgE CH3 peptide vaccine
- Patent Title (中): IgE CH3肽疫苗
-
Application No.: US14225258Application Date: 2014-03-25
-
Publication No.: US09249233B2Publication Date: 2016-02-02
- Inventor: Brian Robert Champion , David Robert Stead , Paul Andrew Wright
- Applicant: Pfizer Vaccines LLC
- Applicant Address: US NY New York
- Assignee: Pfizer Vaccines LLC
- Current Assignee: Pfizer Vaccines LLC
- Current Assignee Address: US NY New York
- Agent Austin W. Zhang
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K17/06 ; A61K39/00 ; C07K16/42 ; A61K39/44 ; A61K47/48 ; A61K38/10 ; A61K39/385 ; C07K4/12 ; C07K7/08
Abstract:
The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Public/Granted literature
- US20150118256A1 IGE CH3 Peptide Vaccine Public/Granted day:2015-04-30
Information query
